NOVARTIS A G's ticker is NVS and the CUSIP is 66987V109. A total of 1,197 filers reported holding NOVARTIS A G in Q3 2023. The put-call ratio across all filers is 1.00 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $6,000 | -97.4% | 80 | -97.2% | 0.01% | -94.8% |
| Q3 2021 | $230,000 | -29.4% | 2,827 | -21.0% | 0.23% | -8.7% |
| Q2 2021 | $326,000 | -51.6% | 3,577 | -54.7% | 0.25% | -53.9% |
| Q1 2021 | $674,000 | +28.9% | 7,896 | +425.0% | 0.55% | +15.3% |
| Q4 2020 | $523,000 | +8.5% | 1,504 | -72.9% | 0.48% | -12.8% |
| Q3 2020 | $482,000 | -0.4% | 5,542 | 0.0% | 0.55% | -14.7% |
| Q2 2020 | $484,000 | -8.7% | 5,542 | -13.9% | 0.64% | -31.8% |
| Q1 2020 | $530,000 | -40.0% | 6,438 | -31.0% | 0.94% | -26.0% |
| Q4 2019 | $884,000 | +18.2% | 9,327 | +8.4% | 1.27% | +122.1% |
| Q3 2019 | $748,000 | -16.5% | 8,604 | -12.2% | 0.57% | +252.5% |
| Q2 2019 | $896,000 | -1.6% | 9,805 | +4.0% | 0.16% | -6.4% |
| Q1 2019 | $911,000 | +85.2% | 9,424 | +64.4% | 0.17% | +66.3% |
| Q4 2018 | $492,000 | – | 5,731 | – | 0.10% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GODSEY & GIBB, INC | 184,900 | $15,121,000 | 6.74% |
| Martin Investment Management, LLC | 289,924 | $23,710,000 | 5.98% |
| Camber Capital Management LP | 2,000,000 | $163,560,000 | 5.04% |
| MANAGED ASSET PORTFOLIOS, LLC | 381,778 | $31,222,000 | 4.76% |
| PROFESSIONAL ADVISORY SERVICES INC | 267,779 | $21,899,000 | 3.22% |
| SCHARF INVESTMENTS, LLC | 1,244,711 | $101,794,000 | 3.21% |
| GARLAND CAPITAL MANAGEMENT INC | 50,755 | $4,151,000 | 2.97% |
| First Fiduciary Investment Counsel, Inc. | 167,378 | $13,688,000 | 2.67% |
| WILKINS INVESTMENT COUNSEL INC | 130,590 | $10,680,000 | 2.61% |
| Lowell Blake & Associates Inc. | 66,309 | $5,423,000 | 2.52% |